BeiGene, Ltd.'s Net Worth
$14.7 Million
Who is BeiGene, Ltd.?
BeiGene, Ltd. has an estimated net worth of $14.7 Million. This is based on reported shares in LEAP THERAPEUTICS, INC..
SEC CIK
BeiGene, Ltd.'s CIK is 0001651308
Past Insider Trading and Trends
2021 was BeiGene, Ltd.'s most active year for acquiring shares with 1 total transactions. BeiGene, Ltd.'s most active month to acquire stocks was the month of August. 2021 saw BeiGene, Ltd. paying a total of $7,249,830.00 for 2,543,800 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LEAP THERAPEUTICS, INC. (LPTX) Snapshot price: $2.99
InvestorBeiGene, Ltd. owns 7,348,437 units of Common Stock which is worth $21,971,826.63. In the year 2020 BeiGene, Ltd. acquired a total of 2,543,800 shares in LEAP THERAPEUTICS, INC. at a cost of $7,249,830.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +52.94% | 2.54M |
$2.85 | $7,249,830.00 | 7.35M |
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||